# FDA Warning Letter: K.C. Pharmaceuticals Inc.
> 2023-08-29 · Division of Pharmaceutical Quality Operations IV · `a50547e665420fb1`
## Letter
- **Company:** K.C. Pharmaceuticals Inc.
- **Posted Date:** 2023-08-29
- **Letter Issue Date:** 2023-08-03
- **Issuing Office:** Division of Pharmaceutical Quality Operations IV
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*